Effect of the kallikrein inhibitor aprotinin on myocardial ischemic injury after coronary occlusion in the dog.
D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use*; D003097:Collateral Circulation / Q000187:drug effects; D003250:Constriction; D003326:Coronary Circulation / Q000187:drug effects; D003331:Coronary Vessels; D003402:Creatine Kinase / Q000378:metabolism; D004195:Disease Models, Animal; D004285:Dogs; D004562:Electrocardiography; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000209:etiology; D009206:Myocardium / Q000201:enzymology / Q000473:pathology
D007611:Aprotinin; D003402:Creatine Kinase